MYLK2 Blocking Peptide for STJ501837 peptide (STJ505593)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within aino acid region 200-250 on human Myosin light chain kinase 2 protein.
General Information
| Short Description | MYLK2 Blocking Peptide for STJ501837 is synthetically produced from the 200-250 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Gene Symbol | MYLK2 |
| Gene ID | 85366 |
| Uniprot ID | MYLK2_HUMAN |
| Immunogen | Synthetic peptide taken within aino acid region 200-250 on human Myosin light chain kinase 2 protein. |
| Immunogen Region | 200-250 |
| Specificity | This blocking peptide is recommended for use in combination with MYLK2 antibody, STJ501837 |
Additional Info
| Tissue Specificity | Heart and skeletal muscles. Increased expression in the apical tissue compared to the interventricular septal tissue. |
| Function | Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N-terminus of a myosin light chain. |
| Peptide Name | Myosin Light Chain Kinase 2 - Skeletal/Cardiac MuscleMlck2 |
| Cellular Localisation | CytoplasmColocalizes With Phosphorylated Myosin Light Chain (Rlcp) At Filaments Of The Myofibrils |
| Alternative Peptide Names | Myosin Light Chain Kinase 2 - Skeletal/Cardiac Muscle proteinMlck2 proteinMYLK2 protein |
Information sourced from Uniprot.org